US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 2.490
  • -0.200-7.43%
Close Dec 13 16:00 ET
  • 2.500
  • +0.010+0.40%
Post 19:59 ET
662.64MMarket Cap-2.04P/E (TTM)

Autolus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-90.95%-76.74M
-33.91%-51.08M
4.49%-40.51M
-29.63%-145.59M
-70.49%-24.83M
-25.97%-40.19M
-23.82%-38.15M
-21.09%-42.42M
4.71%-112.31M
-59.05%-14.57M
Net income from continuing operations
-79.05%-82.09M
-27.92%-58.27M
-32.35%-52.69M
-40.01%-208.38M
-186.34%-77.17M
-7.20%-45.85M
-8.31%-45.55M
-7.42%-39.81M
-4.75%-148.84M
35.32%-26.95M
Operating gains losses
-338.04%-14.09M
83.73%-533K
108.33%1.68M
-184.53%-3.81M
-20.46%-7.26M
11.73%5.92M
---3.28M
--804K
571.28%4.51M
---6.03M
Depreciation and amortization
40.54%1.94M
25.33%1.9M
-4.90%1.81M
-11.55%6.57M
7.64%1.78M
-22.83%1.38M
-21.21%1.51M
-8.13%1.9M
-12.25%7.42M
-21.63%1.65M
Deferred tax
29.41%-168K
185.06%74K
-18.97%-232K
-267.91%-986K
-246.08%-466K
-48.75%-238K
65.61%-87K
-12.07%-195K
-272.22%-268K
175.95%319K
Other non cash items
91.52%11.65M
91.04%11.32M
244.06%20.4M
299.09%49.15M
353.13%31.22M
232.71%6.08M
227.58%5.93M
231.17%5.93M
154.99%12.32M
42.98%6.89M
Change In working capital
118.66%2M
-1,434.88%-8.92M
-2.24%-13.75M
-45.52%292K
287.64%23.8M
-775.90%-10.72M
272.16%668K
-237.06%-13.45M
30.73%536K
-66.23%6.14M
-Change in prepaid assets
5.47%-4.79M
-254.40%-6.67M
-150.19%-10.11M
223.62%13.36M
86.92%18.14M
52.56%-5.06M
194.03%4.32M
23.01%-4.04M
-262.45%-10.81M
-65.62%9.71M
-Change in payables and accrued expense
1,797.13%8.27M
-182.09%-834K
66.24%-2.46M
-96.95%489K
1,019.47%7.24M
-105.08%-487K
-75.72%1.02M
-550.12%-7.28M
517.75%16.03M
110.90%647K
-Change in other current liabilities
71.42%-1.48M
69.65%-1.42M
44.36%-1.18M
-189.20%-13.56M
---1.59M
---5.17M
---4.67M
---2.13M
-94.89%-4.69M
----
Cash from discontinued investing activities
Operating cash flow
-90.95%-76.74M
-33.91%-51.08M
4.49%-40.51M
-29.63%-145.59M
-70.49%-24.83M
-25.97%-40.19M
-23.82%-38.15M
-21.09%-42.42M
4.71%-112.31M
-59.05%-14.57M
Investing cash flow
Cash flow from continuing investing activities
-540.12%-9.59M
80.84%-841K
85.28%-533K
-1.34%-10.99M
-133.33%-1.48M
77.96%-1.5M
-66.25%-4.39M
-369.78%-3.62M
-22.40%-10.84M
60.06%-633K
Net PPE purchase and sale
-540.12%-9.59M
80.84%-841K
85.28%-533K
-1.34%-10.99M
-133.33%-1.48M
77.96%-1.5M
-66.25%-4.39M
-369.78%-3.62M
-22.40%-10.84M
60.06%-633K
Cash from discontinued investing activities
Investing cash flow
-540.12%-9.59M
80.84%-841K
85.28%-533K
-1.34%-10.99M
-133.33%-1.48M
77.96%-1.5M
-66.25%-4.39M
-369.78%-3.62M
-22.40%-10.84M
60.06%-633K
Financing cash flow
Cash flow from continuing financing activities
4,525.00%185K
-849.32%-2.08M
81,350.51%561.44M
-100.39%-883K
-99.99%23K
-96.08%4K
-219K
-69,000.00%-691K
-21.28%223.61M
51.62%223.51M
Net common stock issuance
--0
--0
--549.98M
--0
--0
--0
--0
--0
-33.37%163.85M
----
Proceeds from stock option exercised by employees
4,525.00%185K
--125K
--285K
-76.92%27K
--23K
--4K
--0
--0
-6.40%117K
--0
Net other financing activities
--0
-906.39%-2.2M
1,717.80%11.18M
-101.53%-910K
--0
--0
---219K
-69,000.00%-691K
56.79%59.64M
--59.66M
Cash from discontinued financing activities
Financing cash flow
4,525.00%185K
-849.32%-2.08M
81,350.51%561.44M
-100.39%-883K
-99.99%23K
-96.08%4K
---219K
-69,000.00%-691K
-21.28%223.61M
51.62%223.51M
Net cash flow
Beginning cash position
129.66%706.96M
121.21%759.54M
-37.21%240.34M
23.20%382.76M
57.22%256.85M
42.01%307.83M
27.69%343.36M
23.20%382.76M
101.63%310.68M
-5.71%163.37M
Current changes in cash
-106.67%-86.14M
-26.31%-54M
1,213.57%520.39M
-256.73%-157.46M
-112.62%-26.29M
-7.99%-41.68M
-27.83%-42.76M
-30.53%-46.73M
-36.15%100.46M
52.42%208.31M
Effect of exchange rate changes
505.57%37.72M
-80.39%1.42M
-116.18%-1.19M
152.97%15.03M
-11.82%9.77M
37.13%-9.3M
138.71%7.23M
222.47%7.33M
-3,663.40%-28.38M
1,409.95%11.08M
End cash Position
156.39%658.54M
129.66%706.96M
121.21%759.54M
-37.21%240.34M
-37.21%240.34M
57.22%256.85M
42.01%307.83M
27.69%343.36M
23.20%382.76M
23.20%382.76M
Free cash flow
-107.09%-86.33M
-22.07%-51.92M
10.85%-41.05M
-27.14%-156.57M
-73.10%-26.31M
-7.71%-41.69M
-27.17%-42.54M
-28.60%-46.04M
2.82%-123.15M
-41.48%-15.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -90.95%-76.74M-33.91%-51.08M4.49%-40.51M-29.63%-145.59M-70.49%-24.83M-25.97%-40.19M-23.82%-38.15M-21.09%-42.42M4.71%-112.31M-59.05%-14.57M
Net income from continuing operations -79.05%-82.09M-27.92%-58.27M-32.35%-52.69M-40.01%-208.38M-186.34%-77.17M-7.20%-45.85M-8.31%-45.55M-7.42%-39.81M-4.75%-148.84M35.32%-26.95M
Operating gains losses -338.04%-14.09M83.73%-533K108.33%1.68M-184.53%-3.81M-20.46%-7.26M11.73%5.92M---3.28M--804K571.28%4.51M---6.03M
Depreciation and amortization 40.54%1.94M25.33%1.9M-4.90%1.81M-11.55%6.57M7.64%1.78M-22.83%1.38M-21.21%1.51M-8.13%1.9M-12.25%7.42M-21.63%1.65M
Deferred tax 29.41%-168K185.06%74K-18.97%-232K-267.91%-986K-246.08%-466K-48.75%-238K65.61%-87K-12.07%-195K-272.22%-268K175.95%319K
Other non cash items 91.52%11.65M91.04%11.32M244.06%20.4M299.09%49.15M353.13%31.22M232.71%6.08M227.58%5.93M231.17%5.93M154.99%12.32M42.98%6.89M
Change In working capital 118.66%2M-1,434.88%-8.92M-2.24%-13.75M-45.52%292K287.64%23.8M-775.90%-10.72M272.16%668K-237.06%-13.45M30.73%536K-66.23%6.14M
-Change in prepaid assets 5.47%-4.79M-254.40%-6.67M-150.19%-10.11M223.62%13.36M86.92%18.14M52.56%-5.06M194.03%4.32M23.01%-4.04M-262.45%-10.81M-65.62%9.71M
-Change in payables and accrued expense 1,797.13%8.27M-182.09%-834K66.24%-2.46M-96.95%489K1,019.47%7.24M-105.08%-487K-75.72%1.02M-550.12%-7.28M517.75%16.03M110.90%647K
-Change in other current liabilities 71.42%-1.48M69.65%-1.42M44.36%-1.18M-189.20%-13.56M---1.59M---5.17M---4.67M---2.13M-94.89%-4.69M----
Cash from discontinued investing activities
Operating cash flow -90.95%-76.74M-33.91%-51.08M4.49%-40.51M-29.63%-145.59M-70.49%-24.83M-25.97%-40.19M-23.82%-38.15M-21.09%-42.42M4.71%-112.31M-59.05%-14.57M
Investing cash flow
Cash flow from continuing investing activities -540.12%-9.59M80.84%-841K85.28%-533K-1.34%-10.99M-133.33%-1.48M77.96%-1.5M-66.25%-4.39M-369.78%-3.62M-22.40%-10.84M60.06%-633K
Net PPE purchase and sale -540.12%-9.59M80.84%-841K85.28%-533K-1.34%-10.99M-133.33%-1.48M77.96%-1.5M-66.25%-4.39M-369.78%-3.62M-22.40%-10.84M60.06%-633K
Cash from discontinued investing activities
Investing cash flow -540.12%-9.59M80.84%-841K85.28%-533K-1.34%-10.99M-133.33%-1.48M77.96%-1.5M-66.25%-4.39M-369.78%-3.62M-22.40%-10.84M60.06%-633K
Financing cash flow
Cash flow from continuing financing activities 4,525.00%185K-849.32%-2.08M81,350.51%561.44M-100.39%-883K-99.99%23K-96.08%4K-219K-69,000.00%-691K-21.28%223.61M51.62%223.51M
Net common stock issuance --0--0--549.98M--0--0--0--0--0-33.37%163.85M----
Proceeds from stock option exercised by employees 4,525.00%185K--125K--285K-76.92%27K--23K--4K--0--0-6.40%117K--0
Net other financing activities --0-906.39%-2.2M1,717.80%11.18M-101.53%-910K--0--0---219K-69,000.00%-691K56.79%59.64M--59.66M
Cash from discontinued financing activities
Financing cash flow 4,525.00%185K-849.32%-2.08M81,350.51%561.44M-100.39%-883K-99.99%23K-96.08%4K---219K-69,000.00%-691K-21.28%223.61M51.62%223.51M
Net cash flow
Beginning cash position 129.66%706.96M121.21%759.54M-37.21%240.34M23.20%382.76M57.22%256.85M42.01%307.83M27.69%343.36M23.20%382.76M101.63%310.68M-5.71%163.37M
Current changes in cash -106.67%-86.14M-26.31%-54M1,213.57%520.39M-256.73%-157.46M-112.62%-26.29M-7.99%-41.68M-27.83%-42.76M-30.53%-46.73M-36.15%100.46M52.42%208.31M
Effect of exchange rate changes 505.57%37.72M-80.39%1.42M-116.18%-1.19M152.97%15.03M-11.82%9.77M37.13%-9.3M138.71%7.23M222.47%7.33M-3,663.40%-28.38M1,409.95%11.08M
End cash Position 156.39%658.54M129.66%706.96M121.21%759.54M-37.21%240.34M-37.21%240.34M57.22%256.85M42.01%307.83M27.69%343.36M23.20%382.76M23.20%382.76M
Free cash flow -107.09%-86.33M-22.07%-51.92M10.85%-41.05M-27.14%-156.57M-73.10%-26.31M-7.71%-41.69M-27.17%-42.54M-28.60%-46.04M2.82%-123.15M-41.48%-15.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data